Results 21 to 30 of about 3,790 (193)

Rapid Identification of DUX4::IGH Fusion in Acute Lymphoblastic Leukemia

open access: yeseJHaem
Introduction DUX4 is rearranged and overexpressed in a subgroup of acute lymphoblastic leukemia (ALL) with B‐precursor phenotype, with a favorable outcome.
Kyoko Moritani   +13 more
doaj   +2 more sources

The FSHD atrophic myotube phenotype is caused by DUX4 expression. [PDF]

open access: yesPLoS ONE, 2011
BACKGROUND:Facioscapulohumeral muscular dystrophy (FSHD) is linked to deletions in 4q35 within the D4Z4 repeat array in which we identified the double homeobox 4 (DUX4) gene.
Céline Vanderplanck   +8 more
doaj   +3 more sources

Estrogen interferes with DUX4 nuclear import

open access: yes, 2023
DUX4 (Double Homeobox Protein 4) pathogenic activity is developed through transcriptional function and is associated with its nuclear localization. Three monopartite nuclear localization signals (NLS) are present in DUX4, but their function has not been ...
Fabiola Moretti   +7 more
core   +2 more sources

DUX4, the rockstar of embryonic genome activation?

open access: yesThe International Journal of Developmental Biology
During the initial days of development, the embryo gradually shifts from reliance on maternally provided RNAs and proteins to regulation of its own development. This transition is marked by embryonic genome activation (EGA).
Nykänen, Sonja, Vuoristo, Sanna
core   +5 more sources

CIC-DUX4 sarcomas

open access: yesCurrent Opinion in Oncology, 2022
Purpose of review CIC-DUX4 sarcoma (CDS) is a high-grade undifferentiated round cells sarcoma that belongs to the undifferentiated round cell sarcomas family. It represents less than one percent of sarcomas, defining a rarest among rare malignancies. It affects young adults, displaying soft tissue mass.
Brahmi, Mehdi   +4 more
openaire   +3 more sources

CIC-DUX4 Sarcoma

open access: yesJournal of Medical Sciences, 2022
CIC-DUX4 sarcoma is highly aggressive and rapidly develops lethal metastatic disease and chemoresistance. Its histology is similar to that of Ewing sarcoma and other small round cell sarcomas. Correlation with clinical data, radiological findings, pathological results (including immunohistochemistry and fluorescence in situ ...
Chang-Hung Liao   +3 more
openaire   +2 more sources

Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma [PDF]

open access: yesOncogenesis, 2021
AbstractCIC-DUX4 sarcoma (CDS) is a highly aggressive and metastatic small round type of predominantly pediatric sarcoma driven by a fusion oncoprotein comprising the transcriptional repressor Capicua (CIC) fused to the C-terminal transcriptional activation domain of DUX4.
Darko Bosnakovski   +10 more
openaire   +3 more sources

Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. [PDF]

open access: yesPLoS Genetics, 2010
Each unit of the D4Z4 macrosatellite repeat contains a retrotransposed gene encoding the DUX4 double-homeobox transcription factor. Facioscapulohumeral dystrophy (FSHD) is caused by deletion of a subset of the D4Z4 units in the subtelomeric region of ...
Lauren Snider   +10 more
doaj   +1 more source

A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy

open access: yesMolecular Therapy: Nucleic Acids, 2020
Facioscapulohumeral dystrophy (FSHD) is characterized by a loss of repressive epigenetic marks leading to the aberrant expression of the DUX4 transcription factor. In muscle, DUX4 acts as a poison protein though the induction of multiple downstream genes.
Virginie Mariot   +5 more
doaj   +1 more source

Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy

open access: yesNature Communications, 2021
Facioscapulohumeral muscular dystrophy is a myopathy caused by aberrant de-repression of the DUX4 gene. Here, the authors show that miR-675 inhibits DUX4 expression and protects muscles from DUX4-mediated cell death when administered to mice using AAV ...
Nizar Y. Saad   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy